NCT00574184|CompletedDMC
Pelvic Angiography in Non-Responders to Phosphodiesterase-5 Inhibitors (PANPI)
PANPI
Loading search results
PANPI
Sponsor study identifier
observational
10
0 countries
N/A
Study Start
August 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2008
Actual (reported)Study Completion
March 2008
Actual (reported)The specific aim of this pilot study is to describe the angiographic prevalence and pattern of internal pudendal artery (and associated inflow vessel) atherosclerosis in patients with erectile dysfunction who are non-responsive to PDE-5 inhibitors (i.e., Viagra) who are referred for clinically-indicated cardiac catheterization.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 2008
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 2005
Date type not reportedThis date has not been verified as actual or estimated.
December 13, 2007
Actual (reported)December 17, 2007
Actual (reported)March 2008
Actual (reported)March 2008
Actual (reported)Distal aortography with iliofemoral run-off will be performed to evaluate disease in the common and internal iliac arteries.
During Procedural Cath
Selective angiography of the internal pudendal artery (and accessory pudendal artery if present) will be performed bilaterally.
During Procedural Cath
Intra-arterial nitroglycerin (or papaverine or tolazoline if nitroglycerin is contraindicated) will be used to facilitate angiographic visualization of the internal pudendal and penile arteries.
During Procedural Cath
Subjects will include males who are scheduled to undergo cardiac catheterization or peripheral arteriography at UC Davis Medical Center who have erectile dysfunction and poor response to oral phosphodiesterase-5 inhibitors (Viagra, Cialis and Levitra) as determined by their response to a standardized questionnaire. Dissatisfaction will be defined as a score of 21 or less on the ILEF-5 (International Index of Erectile Function questionnaire).
Jason Rogers, MD
University of California, Davis
10 participants (actual enrollment reported by the registry).
First Submitted
December 13, 2007
First Posted
December 17, 2007
Study Start
August 2005
Date type not reportedThis date has not been verified as actual or estimated.
Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk
Contact the study team to confirm eligibility.
Primary Completion
March 2008
Actual (reported)Study Completion
March 2008
Actual (reported)Last Updated
October 31, 2017
Record last verified: 2008-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: